Skip Navigation


QJM Advance Access originally published online on July 22, 2006
QJM 2006 99(8):545-553; doi:10.1093/qjmed/hcl074
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/8/545    most recent
hcl074v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sumi, K.
Right arrow Articles by Mishima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumi, K.
Right arrow Articles by Mishima, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Effect of nCPAP therapy on heart rate in patients with obstructive sleep apnoea-hypopnoea

K. Sumi1, K. Chin2,, K. Takahashi1, T. Nakamura1, H. Matsumoto1, A. Niimi1 and M. Mishima1

From the 1Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, and2Department of Physical Therapeutics, Kyoto University Hospital of Medicine, Kyoto, Japan

Address correspondence to Dr K. Chin, Department of Physical Therapeutics, Kyoto University Hospital of Medicine, 54 Shogoin Kawahara-cho, Sakyo-Ku, 606-8507 Kyoto, Japan. email: chink{at}kuhp.kyoto-u.ac.jp

Received 2 February 2006 and in revised form 5 May 2006

Background: Elevated heart rate (HR) is a risk factor for cardiovascular disease. The effects of obstructive sleep apnoea-hypopnoea syndrome (OSAHS) on HR are controversial.

Aim: To investigate the effect of nasal continuous positive airway pressure (nCPAP) therapy on HR in OSAHS patients.

Methods: Sixty-two OSAHS patients underwent 24-h electrocardiographic recording, both before and 3 or 4 days after instigation of nCPAP.

Results: After nCPAP was started, HR significantly decreased (mean ± SD 71.8 ± 10.6 vs. 67.5 ± 9.4 bpm, p < 0.0001), both in the daytime (0600–2200 h, 76.3 ± 12.2 vs. 72.2 ± 10.2 bpm, p < 0.0001) and at night-time (2200–0600 h, 64.5 ± 9.1 vs. 60.0 ± 8.9 bpm, p < 0.0001). HR was significantly reduced in both periods in the 44 patients with hypertension and/or diabetes mellitus, but only during the night-time in the 18 with neither condition. Before nCPAP treatment, HR was positively correlated with percentage time of arterial O2 saturation <90% during sleep (p = 0.008) and with the apnoea-hypopnoea index during sleep (p = 0.003). In 15 patients undergoing HR for 2 days before starting nCPAP, the mean HRs for the two periods were similar (p = 0.95).

Discussion: nCPAP therapy appears to decrease HR in OSAHS patients, and may thereby reduce their risk of cardiovascular disease.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Respir JHome page
J. F. Garvey, C. T. Taylor, and W. T. McNicholas
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation
Eur. Respir. J., May 1, 2009; 33(5): 1195 - 1205.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.